FDA Import Refusal 799-5358278-1/11/3 — Aimil Pharmaceuticals India
The FDA refused shipment 799-5358278-1/11/3 from Aimil Pharmaceuticals India (India) on Jan 24, 2025. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 24, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA26 METFORMIN (ANTI-DIABETIC)
- Charges
- 75